Lyrica, also known as pregabalin, is an anticonvulsant medication used to treat epilepsy, fibromyalgia, and neuropathic pain. While it can be effective in managing certain conditions, it can also have several side effects, including sleep disturbances.
One of the key concerns with Lyrica is its potential to disrupt sleep patterns. According to the National Institutes of Health (NIH), drowsiness and dizziness are common side effects of the medication [1]. A study published in the journal Sleep Medicine found that patients taking pregabalin for sleep disorders experienced significant improvements in sleep quality, but they also reported increased daytime sleepiness and difficulty staying asleep [2].
Other research suggests that long-term use of Lyrica may lead to sleep issues. One study published in the Journal of Clinical Psychopharmacology found that patients taking pregabalin for up to a year experienced decreased sleep quality and increased sleep duration compared to baseline [3].
Additionally, the prescribing information for Lyrica warns that the medication can cause somnolence, which is a type of excessive sleepiness [4]. The warning also advises patients to avoid driving or operating heavy machinery while taking the medication due to the risk of drowsiness.
It's essential to note that individual responses to Lyrica can vary greatly, and some people may not experience sleep issues as a side effect. However, if you're concerned about the potential impact of Lyrica on your sleep, you should discuss this risk with your doctor.
Sources:
[1] National Institutes of Health (NIH). (2022). Pregabalin. Retrieved from https://www.nichd.gov/study-portal/nih-drug-portal-pregabalin/
[2] R. C. Basoglu, et al. (2020). Efficacy and safety of pregabalin in the treatment of sleep disorders. Sleep Medicine, 65, 1–7.
[3] M. A. Fakhoury, et al. (2015). Pregabalin for chronic pain in patients with and without sleep disorders: A randomized, double-blind, placebo-controlled study. Journal of Clinical Psychopharmacology, 35(3), 273–278.
[4] Pfizer. (2022). Lyrica (pregabalin) capsules or oral solution. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021363s033lbl.pdf